| Name | Country | Symposia | Chair | Symposia Title | Date | Time | Title of Talk | |
| Arnold Munnich | France | PL01 | Plenary Speaker | Dealing with the coming tsunami of whole genome sequencing | May-05 | 08:00-09:00 | **Not Supplied** | |
| Alan Mackay-Sim | Australia | PL02 | Plenary Speaker | What can we reasonably expect from stem cell therapy- beyond the hype and the hope? | May-05 | 09:00-10:00 | **Not Supplied** | |
| Patrice L. Weiss | Israel | PL03 | Plenary Speaker | The new technologies in neurorehabilitation | May-06 | 08:00-09:00 | **Not Supplied** | |
| Orvar Eeg-Olofsson | Sweden | PL04 | Plenary Speaker | The impact of brain maturation on EEG development in childhood and some electroclinical syndromes | May-06 | 09:00-10:00 | **Not Supplied** | |
| Naila Zaman Khan | Bangladesh | PL05 | Plenary Speaker | Lessening the burden of neurological disorders in low resource settings: A ground level perspective | May-07 | 08:00-09:00 | **Not Supplied** | |
| Sheffali Gulati | India | PL06 | Plenary Speaker | Establishing a program for neuro-developmental disorders in resource constrained settings: Opportunities and challenges | May-07 | 09:00-10:00 | **Not Supplied** | |
| Adré Jacques du Plessis | USA | PL07 | Plenary Speaker | Fetal Neurology: An emerging subspeciality? | May-08 | 08:00-09:00 | **Not Supplied** | |
| Steven Paul Miller | Canada | PL08 | Plenary Speaker | Brain injury in the newborn - Importance of the everyday | May-08 | 09:00-10:00 | **Not Supplied** | |
| Heather Mefford | USA | S01 | Speaker | Focal Epilepsies - Advances in Genetics | May-05 | 10:30-12:30 | How to approach molecular testing of focal epileptic encephalopathies | |
| Ingrid Scheffer | Australia | S01 | Chair | Focal Epilepsies - Advances in Genetics | May-05 | 10:30-12:30 | Familial focal epilepsy with variable foci – a common molecular focal epilepsy | |
| Rima Nabbout | France | S01 | Speaker | Focal Epilepsies - Advances in Genetics | May-05 | 10:30-12:30 | Migrating focal seizures of infancy, a genetic epileptic encephalopathy | |
| Shinichi Hirose | Japan | S01 | Speaker | Focal Epilepsies - Advances in Genetics | May-05 | 10:30-12:30 | Autosomal dominant nocturnal frontal lobe epilepsy – not just a disorder of nicotinic receptors | |
| Francisco E.C. Cardoso | Brazil | S02 | Speaker | Autoimmune Neuropsychiatric Disorders | May-05 | 10:30-12:30 | Sydenham's chorea: What in new in this old disorder? | |
| Hilla Ben-Pazi | Israel | S02 | Chair | Autoimmune Neuropsychiatric Disorders | May-05 | 10:30-12:30 | Should PANDAS/ CANS be considered separate entity? | |
| Michael R Pranzatelli | USA | S02 | Speaker | Autoimmune Neuropsychiatric Disorders | May-05 | 10:30-12:30 | **Not Supplied** | |
| Russell Dale | Australia | S02 | Speaker | Autoimmune Neuropsychiatric Disorders | May-05 | 10:30-12:30 | pathophysiologic role of anti-NMDA, anti-VGKC and anti-dopamine receptor autoantibodies | |
| Ingrid Tein | Canada | S03 | Chair | Neurometabolic Disorders - Treatment Update | May-05 | 10:30-12:30 | Treatment update in fatty acid oxidation disorders | |
| Linda DeMeirleir | Belgium | S03 | Chair | Neurometabolic Disorders - Treatment Update | May-05 | 10:30-12:30 | Treatment update in lysosomal storage disorders | |
| Rose-Mary Boustany | Lebanon | S03 | Speaker | Neurometabolic Disorders - Treatment Update | May-05 | 10:30-12:30 | Treatment update in neuronal ceroid lipofuscinoses | |
| Salvatore DiMauro | USA | S03 | Speaker | Neurometabolic Disorders - Treatment Update | May-05 | 10:30-12:30 | Treatment update in mitochondrial disorders | |
| Adam Kirton | USA | S04 | Chair | Brain Stimulation in Children - Neurophysiology and Therapeutics | May-05 | 10:30-12:30 | Brain Stimulation | |
| Alexander Rotenberg | USA | S04 | Speaker | Brain Stimulation in Children - Neurophysiology and Therapeutics | May-05 | 10:30-12:30 | **Not Supplied** | |
| Donald Gilbert | USA | S04 | Speaker | Brain Stimulation in Children - Neurophysiology and Therapeutics | May-05 | 10:30-12:30 | **Not Supplied** | |
| JP Lin | UK | S04 | Speaker | Brain Stimulation in Children - Neurophysiology and Therapeutics | May-05 | 10:30-12:30 | **Not Supplied** | |
| Heung Dong Kim | South Korea | S05 | Chair | Genetics in Infantile Epileptic Encephalopathy | May-06 | 10:30-12:30 | Genetics in infantile epileptic encephalopathy | |
| Hoon-Chul Kang | Japan | S05 | Speaker | Genetics in Infantile Epileptic Encephalopathy | May-06 | 10:30-12:30 | Genetic mechanisms underlying developmental brain malformations in infantile epilepsy | |
| Ingrid Scheffer | Australia | S05 | Speaker | Genetics in Infantile Epileptic Encephalopathy | May-06 | 10:30-12:30 | Dravet Syndrome: Update in 2013 | |
| Shinichi Hirose | Japan | S05 | Chair | Genetics in Infantile Epileptic Encephalopathy | May-06 | 10:30-12:30 | Spectrum of PCDH19 Mutations | |
| Yuwu Jiang | China | S05 | Speaker | Genetics in Infantile Epileptic Encephalopathy | May-06 | 10:30-12:30 | Expanding genetic and molecular targets of epilepsy in infancy | |
| Bwee-Tien Poll-The | The Netherlands | S06 | Speaker | Leukoencephalopathies | May-06 | 10:30-12:30 | Peroxisomal leukoencephalopathy | |
| Deborah Renaud | USA | S06 | Chair | Leukoencephalopathies | May-06 | 10:30-12:30 | Leukoencephalopathies associated with macrocephaly | |
| Sakkubai Naidu | USA | S06 | Speaker | Leukoencephalopathies | May-06 | 10:30-12:30 | Clinical approach to leukodystrophies | |
| Hans Forssberg | Sweden | S07 | Speaker | Cerebral Palsy | May-06 | 10:30-12:30 | Motor Dysfunctions in Cerebral Palsy based on Used Induced Plasticity | |
| Michael Johnston | USA | S07 | Chair | Cerebral Palsy | May-06 | 10:30-12:30 | Neuroprotection to reduce incidence of CP | |
| Michael Shevell | Canada | S07 | Speaker | Cerebral Palsy | May-06 | 10:30-12:30 | Heterogeniety of CP Population Based Perspectives | |
| Pratibha Singhi | India | S07 | Chair | Cerebral Palsy | May-06 | 10:30-12:30 | **Not Supplied** | |
| David Rothner | USA | S08 | Speaker | Childhood Headaches: Current Treatments and Research | May-06 | 10:30-12:30 | **Not Supplied** | |
| Eric M. Pearlman | USA | S08 | Speaker | Childhood Headaches: Current Treatments and Research | May-06 | 10:30-12:30 | **Not Supplied** | |
| Kenneth Mack | USA | S08 | Chair | Childhood Headaches: Current Treatments and Research | May-06 | 10:30-12:30 | **Not Supplied** | |
| Marco Antônio Arruda | Brazil | S08 | Speaker | Childhood Headaches: Current Treatments and Research | May-06 | 10:30-12:30 | **Not Supplied** | |
| Matti Sillanpää | Finland | S08 | Speaker | Childhood Headaches: Current Treatments and Research | May-06 | 10:30-12:30 | **Not Supplied** | |
| Andrew Kornberg | Australia | S09 | Chair | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | **Not Supplied** | |
| Angelo Ghezzi | Italy | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Therapy in Paediatric MS | |
| Brenda Banwell | USA | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Environmental and Genetic Factors in Paediatric MS | |
| Evangeline Wassmer | UK | S09 | Chair | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | **Not Supplied** | |
| Lauren Krupp | USA | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Neuropsychology of Pediatric MS | |
| Marc Tardieu | France | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Paediatric MS and Demyelinating disorders | |
| Silvia Tenembaum | Argentina | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Paediatric MS and Demyelinating disorders | |
| Tanuja Chitnis | USA | S09 | Speaker | Paediatric Demyelinating and Multiple Sclerosis | May-07 | 10:30-12:30 | Therapy in Paediatric MS | |
| Jonathan Mink | USA | S10 | Chair | Genetic Movement Disorders | May-07 | 10:30-12:30 | **Not Supplied** | |
| Kathy Swoboda | USA | S10 | Speaker | Genetic Movement Disorders | May-07 | 10:30-12:30 | ATP1A3 mutations: from rapid-onset dystonia–parkinsonism to alternating hemiplegia of childhood | |
| Laura Silveira Moriyama | Brazil | S10 | Chair | Genetic Movement Disorders | May-07 | 10:30-12:30 | Episodic Movement Disorders of Childhood: new genes and expanding phenotypes | |
| Manju Kurian | UK | S10 | Speaker | Genetic Movement Disorders | May-07 | 10:30-12:30 | Neurotransmitter Disorders: Novel genes, phenotypes and therapeutic strategies | |
| Russell Dale | Australia | S10 | Speaker | Genetic Movement Disorders | May-07 | 10:30-12:30 | Approach to the Genetic Investigation of Movement Disorders | |
| Helen Cross | UK | S11 | Chair | Improving outcomes in childhood epilepsy | May-07 | 10:30-12:30 | Alternative treatments – can we be more targeted? | |
| Lieven Lagae | Belgium | S11 | Chair | Improving outcomes in childhood epilepsy | May-07 | 10:30-12:30 | When does childhood epilepsy become refractory? | |
| Marilisa Guerreiro | Brazil | S11 | Speaker | Improving outcomes in childhood epilepsy | May-07 | 10:30-12:30 | Early onset epilepsies – can surgery improve outcome? | |
| Mary B. Connolly | Canada | S11 | Speaker | Improving outcomes in childhood epilepsy | May-07 | 10:30-12:30 | Are AEDs really effective- what is the evidence base? | |
| Harry Chugani | USA | S12 | Chair | Update on Neuroimaging | May-07 | 10:30-12:30 | **Not Supplied** | |
| Meral Topçu | Turkey | S12 | Speaker | Update on Neuroimaging | May-07 | 10:30-12:30 | Neuroimaging of neurodegenerative disorders | |
| Renzo Guerrini | Italy | S12 | Speaker | Update on Neuroimaging | May-07 | 10:30-12:30 | Neuroimaging in Epilepsy | |
| Jerome Yager | Canada | S13 | Speaker | Frontiers in Neuroprotection of the neonatal brain | May-08 | 10:30-12:30 | Promising strategies of neurprotection for the developing brain | |
| Mary Stenzel-Poore | USA | S13 | Speaker | Frontiers in Neuroprotection of the neonatal brain | May-08 | 10:30-12:30 | Lessons learned from the adult brain on the translation of preconditioning against ischemic injury | |
| Michael Johnston | USA | S13 | Speaker | Frontiers in Neuroprotection of the neonatal brain | May-08 | 10:30-12:30 | Hypothermia and potential strategies to maximize its utility in protecting the developing ischemic brain | |
| Rand Askalan | Canada | S13 | Chair | Frontiers in Neuroprotection of the neonatal brain | May-08 | 10:30-12:30 | **Not Supplied** | |
| Andrew Kornberg | Australia | S14 | Chair | Acute Leukoencephalopathies in Children | May-08 | 10:30-12:30 | **Not Supplied** | |
| Angelo Ghezzi | Italy | S14 | Speaker | Acute Leukoencephalopathies in Children | May-08 | 10:30-12:30 | **Not Supplied** | |
| Lauren Krupp | USA | S14 | Speaker | Acute Leukoencephalopathies in Children | May-08 | 10:30-12:30 | **Not Supplied** | |
| Silvia Tenembaum | Argentina | S14 | Chair | Acute Leukoencephalopathies in Children | May-08 | 10:30-12:30 | **Not Supplied** | |
| Andrew Zimmerman | USA | S15 | Speaker | NeuroInflammation | May-08 | 10:30-12:30 | Inflammatory Component in the Pathogenesis of Autism Spectrum Disorders. | |
| Leonardo deAzevedo | Brazil | S15 | Chair | NeuroInflammation | May-08 | 10:30-12:30 | Neuroinflammation and NeuroImmune Interaction. | |
| Pierre Gressens | France | S15 | Speaker | NeuroInflammation | May-08 | 10:30-12:30 | Perinatal Asphyxia and Neuroinflammation in the Encephalopathy of Prematurity | |
| Russell Dale | Australia | S15 | Speaker | NeuroInflammation | May-08 | 10:30-12:30 | Differential Diagnosis in Multiple Sclerosis and the importance of Cellular and Molecular Parameters Focusing on Personalized Pharmacotherapy. | |
| Carsten Bonneman | USA | S16 | Speaker | Update on Neuromuscular Disorders | May-08 | 10:30-12:30 | Latest in therapies for key neuromuscular disorders | |
| Heinz Jungbluth | UK | S16 | Speaker | Update on Neuromuscular Disorders | May-08 | 10:30-12:30 | Neuromuscular and neurodevelopmental disorders associated with defective autophagy | |
| Jo Wilmshurst | Sout Africa | S16 | Speaker | Update on Neuromuscular Disorders | May-08 | 10:30-12:30 | Standards of care for SMA and DMD | |
| Rosalin Quinlivan | UK | S16 | Chair | Update on Neuromuscular Disorders | May-08 | 10:30-12:30 | Hazardous Neuromuscular disorders | |